Modulo Bio
Los Altos, California, United States · Healthcare · 50 employees
Modulo Bio is reprogramming the brain’s immune system to cure neurodegenerative disorders.
Funding history
- Funding Round — $5.8M — Nov 2024
- Series seed — $3.9M — Jun 2021
Recent signals
- Nov 20, 2024: Raised $5.8M
- Jun 15, 2021: Raised $3.9M in Series seed
See plans & pricing → Track Modulo Bio’s funding, hiring, and signals — with verified contacts — on Fundz.